These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32692894)

  • 1. Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?
    Macciò A; Madeddu C; Caocci G; La Nasa G
    J Thromb Haemost; 2020 Nov; 18(11):3106-3108. PubMed ID: 32692894
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?".
    Richardson E; Carlo-Stella C; Jara R; Vlodavsky I; Iacobelli M; Fareed J; Mo C; O'Gorman P; Yanik G; Palomo M; Diaz-Ricart M; Moraleda JM;
    J Thromb Haemost; 2020 Nov; 18(11):3111-3113. PubMed ID: 32860297
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.
    Sayyadi M; Khosravi M; Ghaznavi-Rad E
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):518-522. PubMed ID: 33506943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2020 Nov; 40(11):1130-1151. PubMed ID: 33006163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?
    Iba T; Levy JH; Maier CL; Connors JM; Levi M
    J Thromb Haemost; 2024 Jun; 22(6):1541-1549. PubMed ID: 38428590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
    Mohamed-Hussein AAR; Aly KME; Ibrahim MAA
    Med Hypotheses; 2020 Nov; 144():109975. PubMed ID: 32531536
    [No Abstract]   [Full Text] [Related]  

  • 8. A proposal for the management of COVID-19-induced coagulopathy in adults.
    Ignacio-Ibarra G; García-Lee MT; González-Ávila AI; García-Chávez J; Guzmán-Chores L; Cruz CL; Lugo-García Y; Juárez-Lara J; García-Vázquez M; Madera-Maldonado CE; Ramos-Peñafiel CO; Majluf-Cruz A
    Gac Med Mex; 2021; 157(2):201-206. PubMed ID: 34270538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
    Agbuduwe C; Basu S
    Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-Care Coagulation Tests Monitoring of Direct Oral Anticoagulants and Their Reversal Therapy: State of the Art.
    Iapichino GE; Bianchi P; Ranucci M; Baryshnikova E
    Semin Thromb Hemost; 2017 Jun; 43(4):423-432. PubMed ID: 28346965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of anticoagulants on coagulation testing.
    van de Kerkhof D; Schmitz E; Moolenaar M; Schellings M; Boer AK; Boonen K
    Clin Chem Lab Med; 2016 Jul; 54(7):e207-10. PubMed ID: 26824980
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 14. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
    Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
    Pluta J; Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients.
    Thachil J
    J Thromb Haemost; 2020 Nov; 18(11):3109-3110. PubMed ID: 32726507
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy but not inflammation in a Streptococcus pneumoniae pneumonia model in rats.
    Aslami H; Haitsma JJ; Hofstra JJ; Florquin S; Dos Santos C; Streutker C; Zhang H; Levi M; Slutsky AS; Schultz MJ
    J Thromb Haemost; 2012 Mar; 10(3):399-410. PubMed ID: 22236057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.